Arcutis Biotherapeutics | ARS: Annual Report to Security Holders
Arcutis Biotherapeutics | DEFA14A: Others
Arcutis Biotherapeutics | DEF 14A: Definitive information statements
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Topper David Joseph
Arcutis Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Topper David Joseph
Arcutis Biotherapeutics | 8-K: Current report
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moore Matthew Richard
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heron Patrick J
Arcutis Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Frazier Life Sciences VIII, L.P.(7.8%),FHM Life Sciences VIII, L.P.(7.8%), etc.
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jennison Associates LLC(10.8%)
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcutis Biotherapeutics | 8-K: Current report
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin
No Data